Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Increasing Flu Vaccination Through Evidence-Based Nudges (INFLUENCE)

10. november 2026 oppdatert av: Elena Azzolini, Istituto Clinico Humanitas

Nudge-based Strategies to Increase Influenza Vaccination Uptake Among Health and Social Care Personnel: a Multicentre Cluster-randomised Trial

This study aims to find out whether changing the wording and content of workplace emails can encourage more healthcare and non-healthcare staff to get a seasonal flu vaccine. The main question is whether emails that highlight the benefits of vaccination, the possible consequences of not getting vaccinated, or vaccination rates among colleagues are more effective than standard information emails.

The study will take place during the 2026-2027 flu vaccination campaign across 17 healthcare and social care organizations in Lombardy, Italy. Approximately 45,000 eligible workers are expected to be included, covering both staff who provide patient care and those in administrative, technical, and support roles.

Workplace groups, such as departments or organizational units, are randomly assigned to one of four email communication approaches:

  • Standard information (control): emails communicating that the vaccination campaign is ongoing and that it is possible to get vaccinated.
  • Benefits of vaccination (gain framing): emails emphasizing the potential benefits of vaccination for workers, patients, colleagues, and the organization.
  • Consequences of not getting vaccinated (loss framing): emails emphasizing the possible risks and negative consequences for workers, patients, colleagues, and the organization.
  • Vaccination among colleagues (social norms): emails and follow-up updates showing vaccination progress and, where possible, comparing vaccination rates in the recipient's workplace group with those in other groups.

Researchers will use existing vaccination and employment records to compare the percentage of workers who receive a flu vaccine in each group by the end of the campaign. They will also examine whether the emails encourage earlier vaccination and whether their effects differ across workplaces and staff groups. Where suitable records are available, they will explore differences in sickness absence during the campaign.

Vaccination will remain voluntary, and all workers will continue to have access to the usual vaccination services. The study involves workplace emails and the use of existing records; no additional medical visits, tests, or procedures are required.

The findings will help healthcare organizations decide whether simple changes to routine communication can improve staff flu vaccination rates and which approach works best.

Studieoversikt

Detaljert beskrivelse

Seasonal influenza represents a major public health issue, associated with morbidity, mortality, pressure on healthcare services, workforce absenteeism and risk of transmission in care settings. Influenza vaccination of healthcare and non-healthcare workers employed in healthcare and social care organisations is an important preventive measure, not only for individual protection, but also for the indirect protection of frail patients, reduction of transmission in healthcare settings, preservation of continuity of care and resilience of healthcare services. Despite the availability of influenza vaccination and public health recommendations, vaccination uptake among healthcare and non-healthcare workers remains suboptimal and variable across organisations, professional profiles and organisational units. Communication strategies informed by behavioural science, commonly referred to as "nudges", represent low-cost, scalable organisational interventions that may guide individuals towards preventive behaviours while preserving individual autonomy. The study aims to evaluate the effectiveness of an organisational and behavioural communication strategy with potential impact on prevention, quality of care pathways, workforce resilience and public health.

Primary objective: to evaluate the effectiveness of nudge-based communication strategies, assigned at organisational cluster level, in increasing influenza vaccination uptake among eligible healthcare and non-healthcare workers during the 2026-2027 influenza vaccination campaign compared with standard institutional communication.

Secondary objectives:

  • to compare the relative effectiveness of the different communication arms, including standard communication, gain framing, loss framing and social norms/peer feedback;
  • to assess the change in influenza vaccination uptake during the 2026-2027 campaign compared with the 2025-2026 campaign, where historical data are available; to evaluate time to vaccination;
  • to explore heterogeneity of effect by organisational cluster, healthcare/non-healthcare area and previous vaccination history, where available;
  • to assess sickness absence indicators at cluster level during the vaccination campaign, where such data are available and comparable across participating organisations;
  • to generate evidence to inform future organisational, regional and potentially national vaccination communication and prevention policies.

Primary endpoint:

Influenza vaccination uptake during the 2026-2027 influenza vaccination campaign, defined as the proportion of eligible healthcare and non-healthcare workers within the randomised clusters who receive influenza vaccination by the end of the observation period. Documented vaccinations will be considered irrespective of the setting in which they are administered, including vaccinations administered within the participating organisation or through other authorised vaccination pathways, where captured by ARVAX or other applicable regional administrative data sources.

Secondary endpoints:

  • Absolute percentage-point change in influenza vaccination uptake between the 2026-2027 campaign and the 2025-2026 campaign, at cluster level;
  • Time to vaccination, defined as the number of days between delivery of the communication assigned to the cluster and the documented date of influenza vaccination;
  • Sickness absence indicators at cluster level during the vaccination campaign, including number of sickness absence days and/or sickness absence rates standardised by eligible population or person-time, according to data availability and quality.

Population and patient selection criteria: The study population consists of healthcare and non-healthcare workers eligible for influenza vaccination during the 2026-2027 campaign and belonging to organisational clusters included in the study within the 17 participating Lombardy organisations.

In this protocol, the term "patients/subjects" should be understood as "study participants/workers", since the study is not conducted on assisted patients. Inclusion criteria: employment or affiliation with one of the 17 participating organisations; belonging to an included and randomised organisational cluster; eligibility for influenza vaccination according to applicable regional/organisational recommendations; availability in administrative data flows required to define the denominator; and availability of vaccination outcome data through administrative, regional or organisational data sources.

Exclusion criteria: non-eligibility for influenza vaccination; lack of minimum data required for denominator definition, cluster attribution or outcome ascertainment; belonging to clusters that are not classifiable, mappable or randomizable; termination of employment/affiliation before the start of the campaign if not exposed to the possibility of organisational vaccination; or any other administrative condition preventing correct attribution to cluster, study arm or outcome.

Study design: This is a pragmatic, multicentre, four-arm, parallel-group, cluster-randomised, non-pharmacological procedural-organisational interventional study, prospectively implemented during the 2026-2027 influenza vaccination campaign. Randomisation will occur at the level of organisational clusters, defined as organisational units uniformly identified across participating centres according to FLUPER or another consistent organisational classification available within the participating organisations. Clusters will be allocated in a 1:1:1:1 ratio to one of four arms: standard communication, gain framing, loss framing, and social norms/peer feedback. Outcomes and denominators will be assessed using routinely available administrative, regional and organisational data flows, including FLUPER, the regional healthcare workforce administrative flow used to support workforce denominator definition and organisational classification, and ARVAX, the regional vaccination registry/database used to ascertain vaccination uptake; where available, organisational workforce or human resources data flows used to assess cluster-level sickness absence indicators will be used.

Description of the intervention: The intervention consists of institutional e-mail communications sent by the Vaccination Unit or the competent organisational function of each participating organisation, with content differentiated according to the study arm assigned to the cluster.

  • Arm 1 - Standard communication: standard e-mail containing information on the launch of the influenza vaccination campaign, access procedures, vaccination sites, opening hours and booking channels.
  • Arm 2 - Gain framing: e-mail emphasising the benefits of vaccination for the worker, patients, colleagues and the organisation.
  • Arm 3 - Loss framing: e-mail emphasising the risks and potential negative consequences of non-vaccination for the worker, patients, colleagues and the organisation.
  • Arm 4 - Social norms / peer feedback: periodic e-mails providing updates on campaign progress and, where feasible, comparison between the vaccination uptake rate of the recipient's cluster and that of other clusters or the overall cluster average.

The comparator is standard/informational communication, corresponding to routine communication on the launch of the vaccination campaign and on access procedures.

Number of participants planned: The overall expected number of participants will be determined based on FLUPER/organisational data flows and other available administrative sources from the 17 participating organisations before final randomisation. All eligible healthcare and non-healthcare workers belonging to the randomised clusters are expected to be included.

Total number planned: approximately 45,000 healthcare and non-healthcare workers across all 17 participating organisations, subject to confirmation based on the final eligible workforce denominator derived from FLUPER and/or organisational administrative data flows before randomisation. Number planned per arm: approximately one quarter of the overall eligible population, depending on the number and size of randomised cluster

Studietype

Intervensjonell

Registrering (Antatt)

45000

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Bergamo, Italia
        • ATS Bergamo
      • Brescia, Italia
        • ASST Spedali Civili di Brescia
      • Crema, Italia
        • ASST Crema
      • Desenzano del Garda, Italia
        • ASST Garda
      • Garbagnate Milanese, Italia
        • ASST Rhodense
      • Legnano, Italia
        • ASST Ovest Milanese
      • Lodi, Italia
        • ASST Lodi
      • Milan, Italia
        • Istituto Europeo di Oncologia
      • Milan, Italia
        • ASST Fatebenefratelli-Sacco
      • Milan, Italia
        • ASST Santi Paolo e Carlo
      • Paderno Dugnano, Italia
        • Clinica Polispecialistica San Carlo
      • Pavia, Italia
        • ASST Pavia
      • Pavia, Italia
        • ATS Pavia
      • Sondrio, Italia
        • ASST Valtellina e Alto Lario
      • Treviglio, Italia
        • ASST Bergamo Ovest
      • Vimercate, Italia
        • ASST Brianza
    • Lombardy
      • Milan, Lombardy, Italia, 20089
        • Istituto Clinico Humanitas

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Barn
  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion criteria:

  • employment or affiliation with one of the 17 participating organisations;
  • belonging to an included and randomised organisational cluster;
  • availability in administrative data flows required to define the denominator;
  • availability of vaccination outcome data through administrative regional data sources.

Exclusion criteria:

  • lack of minimum data required for denominator definition, cluster attribution or outcome ascertainment;
  • belonging to clusters that are not classifiable, mappable or randomizable.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Forebygging
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: Control

Standard communication: standard e-mail informing that the vaccination campaing is ongoing and inviting healthcare workers to participate.

Dear Colleague,

The seasonal flu vaccination campaign is underway.

If you have not yet been vaccinated, please remember that you can receive your vaccination by following the instructions previously provided.

Thank you for your attention and for contributing to this prevention effort.

Eksperimentell: Gain Framing

Gain framing: e-mail emphasising the benefits of vaccination for the worker, patients, colleagues and the organisation.

Dear Colleague,

The seasonal flu vaccination campaign is underway.

Flu is not always a mild illness. Globally, it is estimated to cause 3-5 million cases of severe illness and 290,000-650,000 deaths associated with respiratory disease each year. In Italy, more than 21,000 hospital admissions each year are attributable to flu or related respiratory and cardiovascular complications.

Getting vaccinated against flu protects both individual and community health:

  • It reduces the spread of the flu virus, benefiting care recipients, patients, colleagues, and family members.
  • It reduces the risk of complications in people with chronic conditions.
  • It reduces the risk of a heart attack in the seven days following a confirmed flu infection.

If you have not yet been vaccinated, please remember that you can receive your vaccination by following the instructions previously provided.

Thank you for your attention and for contributing to this prevention effort.

Eksperimentell: Loss framing

Loss framing: e-mail emphasising the risks and potential negative consequences of non-vaccination for the worker, patients, colleagues and the organisation.

Dear Colleague,

The seasonal flu vaccination campaign is underway.

Flu is not always a mild illness. Globally, it is estimated to cause 3-5 million cases of severe illness and 290,000-650,000 deaths associated with respiratory disease each year. In Italy, more than 21,000 hospital admissions each year are attributable to flu or related respiratory and cardiovascular complications.

Not getting vaccinated against flu increases both individual and community risks:

  • It increases the spread of the flu virus, affecting care recipients, patients, colleagues, and family members.
  • It increases the risk of complications in people with chronic conditions.
  • It increases the risk of a heart attack in the seven days following a confirmed flu infection.

If you have not yet been vaccinated, please remember that you can receive your vaccination by following the instructions previously provided.

Thank you for your attention and for contributing to this prevention effort.

Eksperimentell: Social norms

Social norms: weekly e-mails providing updates on campaign progress and comparison between the vaccination uptake rate of the recipient's cluster and that of other clusters assigned to the same experimental arm.

Dear Colleague,

The seasonal flu vaccination campaign is underway.

To encourage staff vaccination, the Agency will send a brief weekly update on the campaign's progress from now through December. These updates will compare vaccination rates across selected organizational units within the Agency. The units were selected at random and were formed by grouping organizational structures with similar areas of activity.

If you have not yet been vaccinated, please remember that you can receive your vaccination by following the instructions previously provided.

Thank you for your attention and for contributing to this prevention effort.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Influenza vaccination uptake at the end of 2026-2027 campaign.
Tidsramme: Up to 6 months

Proportion of eligible healthcare and non-healthcare workers within the randomised clusters who receive influenza vaccination by the end of the observation period of the campaign.

Up to 6 months

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Influenza vaccination uptake at mid 2026-2027 campaign.
Tidsramme: Up to 3 months

Proportion of eligible healthcare and non-healthcare workers within the randomised clusters who receive influenza vaccination at mid of the campaign.

Up to 3 months
Change in influenza vaccination uptake between seasons.
Tidsramme: Baseline and 6 months

Absolute percentage-point change in influenza vaccination uptake between the 2026-2027 campaign and the 2025-2026 campaign.

Baseline and 6 months
Time to vaccination.
Tidsramme: Up to 6 months

The number of days between the delivery of the communication assigned to the cluster and the documented date of influenza vaccination.

Up to 6 months
Sickness absence.
Tidsramme: Up to 6 months

Number of sickness absence days and/or sickness absence rates standardised by eligible population or person-time.

Up to 6 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

21. oktober 2026

Primær fullføring (Antatt)

31. mars 2027

Studiet fullført (Antatt)

31. mars 2027

Datoer for studieregistrering

Først innsendt

30. oktober 2026

Først innsendt som oppfylte QC-kriteriene

10. november 2026

Først lagt ut (Faktiske)

17. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

17. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

10. november 2026

Sist bekreftet

1. oktober 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

No IPD data will be collected as part of the study.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere